This interview examines treatment-related cardiotoxicity and the risk of second malignancy in patients with Hodgkin lymphoma.
Flora van Leeuwen, PhD
Advertisement
Articles by Flora van Leeuwen, PhD
Advertisement
Latest Updated Articles
Late Toxicity of Radiotherapy and Chemotherapy in Hodgkin LymphomaDecember 9th 2016
Advertisement
Advertisement
Trending on CancerNetwork
1
The Case for Frontline Zongertinib in HER2-Mutant NSCLC
2
Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC
3
Acting on a HER2 Result and Navigating Access to Therapy
4
FDA Clears TriNav Advance for Expanded Liver Embolization Access
5